Abstract:To prepare mouse-original monoclon antibody against the product of vvhA gene encoding Vibrio vulnificus cytolysin and to identify its specificity and immunogenicity in order to lay a foundation for develment of a diagnostic kit to detect V. vulnificus,IPTG was used to induce the target recombinant protein rvvhA and Ni-NTA affinity chromatography was applied to extract rvvhA. By using SDS-PAGE plus BioRad Agarose Image Analysor, the effects of expression and purification of rvvhA were determined. The cell lines to secrete anti-rvvhA monoclonal antibodies were prepared and screened by hybridoma technique and rvvhA-ELISA, and then were cloned by limited dilution method. ELISA, immunodiffusion assay and Western blot hybridization were used to tetect the titers and specificity.Under induction with 0.5 mmol/L IPTG, the output of rvvhA could reach 18% of total bacterial proteins. The purified rvvhA only showed a single fragment in gel after SDS-PAGE. Nine cell lines of hybridoma were screened out, and lines A5E8 and C3B6 were found to be continuously secreting specific IgG1 or IgG2a monoclonal antibodies with high titers, respectively. This monoclonal antibodies showed high specificity,not reacting with the proteins from other bacteria.The titers in ELISA and immunodiffusion to rvvhA and the proteins from Vibrio vulnificus strains GTC333 and WZ01 were as high as 1∶4000∶1∶8000 and 1∶4-1∶8, respectively. The result of Western blot hybridization indicated that the monoclonal antibodies could recognize rvvhA efficiently. Two mouse-origin cell lines of hybridoma stably secreting specific monoclonal antibodies against rvvhA were obtained in this study. This anti-rvvhA monoclonal antibodies could be used to detect naturally secreted cytolysin of Vibrio vulnificus.

[Preparation and Characterization of Monoclonal Antibodies Against Micrococcus Luteus Rpf Domain].

[Preparation and Characterization of Monoclonal Antibody Against Human Telomeric Repeat Binding Factor 1].

Production and Characterization of Monoclonal Antibody Against Mycobacterium Tuberculosis RpfB Domain.

[Immune Response Induced by Rpf Domain from Micrococcus Luteus in Mice].

Cloning, purification and identification of Micrococcus luteus Rpf gene

Effects of Micrococcus Luteus Rpf and Rpf Domain Protein on Growth of Mycobacterium Tuberculosis

Expression in E. coli and bioactivity assay of Micrococcus luteus resuscitation promoting factor domain and its mutants

Preparation and identification of monoclonal antibodies against Luman-recruiting factor N-terminal

Preparation and Identification of Monoclonal Antibody Against Cytolysin of Vibrio Vulnificus

Preparation and Characterization of Monoclonal Antibody Against Human Leukocytes

Therapeutic Efficacy of Micrococcus Luteus Rpf Domain and its Mutants against Mycobacterium Tuberculosis in Mice

Preparation and Identification of Monoclonal Antibodies Against Luman-N-term Fusion

Preparation of A Monoclonal Antibody Against Human Von Willebrand Factor A1 Domain

Expression, Purification and Characterization of Mycobacterium Tuberculosis RpfE Protein

Preparation of Polyclonal Antibodies with Recombinant N Terminus of Porcine Lactotransferrin

Expression, Identification and Purification of RpfA Protein from Mycobacterium Tuberculosis

Expression of Mer IgG-like Domain and Its Monoclonal Antibody

Preparation and Identification of Monoclonal Antibodies against Bordetella bronchiseptica from Rabbits

Preparation and Characterization of Monoclonal Antibody to FVIII C1C2 Domain of Human

Preparation and Identification of Monoclonal Antibodies Against Brucella Mel Ribosomal Protein L7/L12

Production and Characterization of Mouse Monoclonal Antibodies Against Lysis Protein E of Phix174